A lightweight CVTC model for accurate Alzheimer's MRI analysis and lesion annotation

一种用于精确进行阿尔茨海默病MRI分析和病灶标注的轻量级CVTC模型

阅读:2

Abstract

In clinical practice, MRI images are widely used to diagnose neurodegenerative diseases like Alzheimer's disease (AD). However, complex MRI patterns often mimic normal aging, relying on subjective experience and risking misdiagnosis. This paper proposes the Cross Vision Transformer with Coordinate (CVTC) to assess AD severity and accurately annotate suspicious lesions, reducing clinicians' burden and improving reliability. CVTC integrates scale-adaptive embedding, dynamic position bias, and long-short attention mechanisms to enhance capture of local and global MRI features. For annotation, the Coordinate and Feature Map Guided Mechanism (CAGM) leverages pixel coordinates and feature maps to compute an importance threshold, generating lesion overlay maps for precise localization. A user-friendly UI is developed to enable intuitive exploration and validation in clinical settings. CVTC demonstrates robust performance across datasets: 98.80% accuracy on ADNI (AD/MCI/CN), 98.51% on AD subtypes (EMCI/LMCI/SMC/CN); cross-dataset validation on tumor and multiple sclerosis MRIs confirms CAGM's annotation accuracy; NACC (96.30%), OASIS-1 (98.16%), and pseudo-RGB datasets (92.96%) highlight superior generalization. Ablation and cross-validation affirm robustness. With a 21.850MB lightweight design, CVTC offers an efficient, accurate tool for diverse clinical applications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。